BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27900936)

  • 21. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
    Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
    World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.
    Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH
    Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma.
    Akinduro OO; Garcia DP; Higgins DMO; Vivas-Buitrago T; Jentoft M; Solomon DA; Daniels DJ; Pennington Z; Sherman WJ; Delgardo M; Bydon M; Kalani MA; Zanazzi G; Tsankova N; Bendok BR; McCormick PC; Sciubba DM; Lo SL; Clarke JL; Abode-Iyamah K; Quiñones-Hinojosa A
    J Neurosurg Spine; 2021 Aug; 35(6):834-843. PubMed ID: 34416733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adult case of diffuse midline glioma with H3 K27M mutation.
    Tu JH; Piao YS; Lu DH; Wang LM; Liu L; Bai DY; Han HW; Lin YK; Zhong S
    Neuropathology; 2020 Dec; 40(6):627-631. PubMed ID: 32954563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of magnetic resonance imaging characteristics in discriminating H3 K27M-mutant gliomas from wildtype gliomas in spinal cord.
    Zhao B; Yao J; Wang J; Li J; Shi W; Zhang C; Zhao X; Qiao J; Ma Y; Xu Y; Zheng Z
    Neurol Sci; 2024 Jun; 45(6):2845-2851. PubMed ID: 38228940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
    Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.
    Gielen GH; Gessi M; Hammes J; Kramm CM; Waha A; Pietsch T
    Am J Clin Pathol; 2013 Mar; 139(3):345-9. PubMed ID: 23429371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K27M midline gliomas display malignant progression by imaging and histology.
    Vettermann FJ; Neumann JE; Suchorska B; Bartenstein P; Giese A; Dorostkar MM; Albert NL; Schüller U
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):458-462. PubMed ID: 27997032
    [No Abstract]   [Full Text] [Related]  

  • 29. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
    Kleinschmidt-DeMasters BK; Mulcahy Levy JM
    Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
    Lopez GY; Oberheim Bush NA; Phillips JJ; Bouffard JP; Moshel YA; Jaeckle K; Kleinschmidt-DeMasters BK; Rosenblum MK; Perry A; Solomon DA
    Acta Neuropathol; 2017 Dec; 134(6):961-963. PubMed ID: 29063183
    [No Abstract]   [Full Text] [Related]  

  • 31. A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor.
    Funata N; Nobusawa S; Nakata S; Yamazaki T; Takabagake K; Koike T; Maegawa T; Yamada R; Shinoura N; Mine Y
    Brain Tumor Pathol; 2018 Jan; 35(1):29-35. PubMed ID: 29264735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
    Al Sharie S; Talafha M; Abu Laban D; Al Awabdeh T; Al-Mousa A; Al-Masri N; Al-Hussaini M
    Clin Neuropathol; 2022; 41(6):263-270. PubMed ID: 35770519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
    Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
    J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas.
    Garcia MR; Feng Y; Vasudevaraja V; Galbraith K; Serrano J; Thomas C; Radmanesh A; Hidalgo ET; Harter DH; Allen JC; Gardner SL; Osorio DS; William CM; Zagzag D; Boué DR; Snuderl M
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):865-872. PubMed ID: 35997552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
    Louis DN; Giannini C; Capper D; Paulus W; Figarella-Branger D; Lopes MB; Batchelor TT; Cairncross JG; van den Bent M; Wick W; Wesseling P
    Acta Neuropathol; 2018 Apr; 135(4):639-642. PubMed ID: 29497819
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic mutations in high grade gliomas of the adult spinal cord.
    Nagaishi M; Nobusawa S; Yokoo H; Sugiura Y; Tsuda K; Tanaka Y; Suzuki K; Hyodo A
    Brain Tumor Pathol; 2016 Oct; 33(4):267-269. PubMed ID: 27236270
    [No Abstract]   [Full Text] [Related]  

  • 38. Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.
    Castel D; Kergrohen T; Tauziède-Espariat A; Mackay A; Ghermaoui S; Lechapt E; Pfister SM; Kramm CM; Boddaert N; Blauwblomme T; Puget S; Beccaria K; Jones C; Jones DTW; Varlet P; Grill J; Debily MA
    Acta Neuropathol; 2020 Jun; 139(6):1109-1113. PubMed ID: 32193787
    [No Abstract]   [Full Text] [Related]  

  • 39. The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
    Feng J; Hao S; Pan C; Wang Y; Wu Z; Zhang J; Yan H; Zhang L; Wan H
    Hum Pathol; 2015 Nov; 46(11):1626-32. PubMed ID: 26297251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.
    Lu VM; Raghunathan A; Schwartz JD; Daniels DJ
    World Neurosurg; 2020 May; 137():472-473. PubMed ID: 32365434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.